{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:17:34Z","timestamp":1788585454799,"version":"build-2803163510"},"reference-count":39,"publisher":"Japan Atherosclerosis Society","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2026]]},"DOI":"10.5551\/jat.66242","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T22:15:06Z","timestamp":1788214506000},"source":"Crossref","is-referenced-by-count":0,"title":["The Waist-to-Height Ratio and Incidence of High LDL Cholesterol in Japanese: A Retrospective Cohort Study"],"prefix":"10.5551","author":[{"given":"Takako","family":"Fujii","sequence":"first","affiliation":[{"name":"Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Kawazoe","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikara","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Sleep Medicine Center, Fukuoka University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yori","family":"Inoue","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Fukuoka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Tada","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Fukuoka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Fukuoka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Fukuoka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Masutani","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Fukuoka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisatomi","family":"Arima","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, Bonny A, Brauer M, Brodmann M, Cahill TJ, Carapetis J, Catapano AL, Chugh SS, Cooper LT, Coresh J, Criqui M, DeCleene N, Eagle KA, Emmons-Bell S, Feigin VL, Fern\u00e1ndez-Sol\u00e0 J, Fowkes G, Gakidou E, Grundy SM, He FJ, Howard G, Hu F, Inker L, Karthikeyan G, Kassebaum N, Koroshetz W, Lavie C, Lloyd-Jones D, Lu HS, Mirijello A, Temesgen AM, Mokdad A, Moran AE, Muntner P, Narula J, Neal B, Ntsekhe M, Moraes de Oliveira G, Otto C, Owolabi M, Pratt M, Rajagopalan S, Reitsma M, Ribeiro ALP, Rigotti N, Rodgers A, Sable C, Shakil S, Sliwa-Hahnle K, Stark B, Sundstr\u00f6m J, Timpel P, Tleyjeh IM, Valgimigli M, Vos T, Whelton PK, Yacoub M, Zuhlke L, Murray C, Fuster V; GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol, 2020; 76: 2982-3021","DOI":"10.1016\/j.jacc.2020.11.010"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Ference BA, Graham I, Tokgozoglu L, Catapano AL. Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series. J Am Coll Cardiol, 2018; 72: 1141-1156","DOI":"10.1016\/j.jacc.2018.06.046"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Cholesterol Treatment Trialists\u2019 (CTT) Collaboration; Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, Collins R. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet, 2010; 376: 1670-1681","DOI":"10.1016\/S0140-6736(10)61350-5"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Domanski MJ, Tian X, Wu CO, Reis JP, Dey AK, Gu Y, Zhao L, Bae S, Liu K, Hasan AA, Zimrin D, Farkouh ME, Hong CC, Lloyd-Jones DM, Fuster V. Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk. J Am Coll Cardiol, 2020; 76: 1507-1516","DOI":"10.1016\/j.jacc.2020.07.059"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Okamura T, Tsukamoto K, Arai H, Fujioka Y, Ishigaki Y, Koba S, Ohmura H, Shoji T, Yokote K, Yoshida H, Yoshida M, Deguchi J, Dobashi K, Fujiyoshi A, Hamaguchi H, Hara M, Harada-Shiba M, Hirata T, Iida M, Ikeda Y, Ishibashi S, Kanda H, Kihara S, Kitagawa K, Kodama S, Koseki M, Maezawa Y, Masuda D, Miida T, Miyamoto Y, Nishimura R, Node K, Noguchi M, Ohishi M, Saito I, Sawada S, Sone H, Takemoto M, Wakatsuki A, Yanai H. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022. J Atheroscler Thromb, 2024; 31: 641-853","DOI":"10.5551\/jat.GL2022"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Imamura T, Doi Y, Arima H, Yonemoto K, Hata J, Kubo M, Tanizaki Y, Ibayashi S, Iida M, Kiyohara Y. LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population: the Hisayama study. Stroke, 2009; 40: 382-388","DOI":"10.1161\/STROKEAHA.108.529537"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Okamura T, Kokubo Y, Watanabe M, Higashiyama A, Miyamoto Y, Yoshimasa Y, Okayama A. Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study. Atherosclerosis, 2009; 203: 587-592","DOI":"10.1016\/j.atherosclerosis.2008.07.020"},{"key":"8","unstructured":"8) NCD Risk Factor Collaboration (NCD-RisC). Repositioning of the global epicentre of non-optimal cholesterol. Nature, 2020; 582: 73-77"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Powell-Wiley TM, Poirier P, Burke LE, Despr\u00e9s JP, Gordon-Larsen P, Lavie CJ, Lear SA, Ndumele CE, Neeland IJ, Sanders P, St-Onge MP; American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; and Stroke Council. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation, 2021; 143: e984-e1010","DOI":"10.1161\/CIR.0000000000000973"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation, 1983; 67: 968-977","DOI":"10.1161\/01.CIR.67.5.968"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Global BMI Mortality Collaboration, Di Angelantonio E, Bhupathiraju ShN, Wormser D, Gao P, Kaptoge S, Berrington de Gonzalez A, Cairns BJ, Huxley R, Jackson ChL, Joshy G, Lewington S, Manson JE, Murphy N, Patel AV, Samet JM, Woodward M, Zheng W, Zhou M, Bansal N, Barricarte A, Carter B, Cerhan JR, Smith GD, Fang X, Franco OH, Green J, Halsey J, Hildebrand JS, Jung KJ, Korda RJ, McLerran DF, Moore SC, O\u2019Keeffe LM, Paige E, Ramond A, Reeves GK, Rolland B, Sacerdote C, Sattar N, Sofianopoulou E, Stevens J, Thun M, Ueshima H, Yang L, Yun YD, Willeit P, Banks E, Beral V, Chen Zh, Gapstur SM, Gunter MJ, Hartge P, Jee SH, Lam TH, Peto R, Potter JD, Willett WC, Thompson SG, Danesh J, Hu FB. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet, 2016; 388: 776-786","DOI":"10.1016\/S0140-6736(16)30175-1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kritchevsky SB, Beavers KM, Miller ME, Shea MK, Houston DK, Kitzman DW, Nicklas BJ. Intentional weight loss and all-cause mortality: a meta-analysis of randomized clinical trials. PLoS One, 2015; 10: e0121993","DOI":"10.1371\/journal.pone.0121993"},{"key":"13","unstructured":"13) World Health Organization, Obesity and overweight. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight. Accessed 8 Oct. 2025"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Ogawa W, Hirota Y, Miyazaki S, Nakamura T, Ogawa Y, Shimomura I, Yamauchi T, Yokote K; Creation Committee for Guidelines for the Management of Obesity Disease 2022 by Japan Society for the Study of Obesity (JASSO). Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan. Endocr J, 2024; 71: 223-231","DOI":"10.1507\/endocrj.EJ23-0593"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA, 2003; 289: 76-79","DOI":"10.1001\/jama.289.1.76"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet, 2004; 363: 157-163","DOI":"10.1016\/S0140-6736(03)15268-3"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Nazare JA, Smith JD, Borel AL, Haffner SM, Balkau B, Ross R, Massien C, Alm\u00e9ras N, Despr\u00e9s JP. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship With Cardiometabolic Risk\/Intra-Abdominal Adiposity. Am J Clin Nutr, 2012; 96: 714-726","DOI":"10.3945\/ajcn.112.035758"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Takase M, Nakamura T, Nakaya N, Kogure M, Hatanaka R, Nakaya K, Chiba I, Kanno I, Nochioka K, Tsuchiya N, Hirata T, Obara T, Ishikuro M, Uruno A, Kobayashi T, Kodama EN, Hamanaka Y, Orui M, Ogishima S, Nagaie S, Fuse N, Sugawara J, Izumi Y, Kuriyama S, Hozawa A; ToMMo investigators. Relationships of Fat Mass Index and Fat-Free Mass Index with Low-Density Lipoprotein Cholesterol Levels in the Tohoku Medical Megabank Community-Based Cohort Study. J Atheroscler Thromb, 2024; 31: 979-1003","DOI":"10.5551\/jat.64535"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Mohammadian Khonsari N, Khashayar P, Shahrestanaki E, Kelishadi R, Mohammadpoor Nami S, Heidari-Beni M, Esmaeili Abdar Z, Tabatabaei-Malazy O, Qorbani M. Normal Weight Obesity and Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis. Front Endocrinol, 2022; 13: 857930","DOI":"10.3389\/fendo.2022.857930"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0\u00b75 could be a suitable global boundary value. Nutr Res Rev, 2010; 23: 247-269","DOI":"10.1017\/S0954422410000144"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Ashwell M, Gibson S. Waist-to-height ratio as an indicator of \u2018early health risk\u2019: simpler and more predictive than using a \u2018matrix\u2019 based on BMI and waist circumference. BMJ Open, 2016; 6: e010159","DOI":"10.1136\/bmjopen-2015-010159"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Jayedi A, Soltani S, Zargar MS, Khan TA, Shab-Bidar S. Central fatness and risk of all cause mortality: systematic review and dose-response meta-analysis of 72 prospective cohort studies. BMJ, 2020; 370: m3324","DOI":"10.1136\/bmj.m3324"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Xue R, Li Q, Geng Y, Wang H, Wang F, Zhang S. Abdominal obesity and risk of CVD: a dose-response meta-analysis of thirty-one prospective studies. Br J Nutr, 2021; 126: 1420-1430","DOI":"10.1017\/S0007114521000064"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Abdi Dezfouli R, Mohammadian Khonsari N, Hosseinpour A, Asadi S, Ejtahed HS, Qorbani M. Waist to height ratio as a simple tool for predicting mortality: a systematic review and meta-analysis. Int J Obes (Lond), 2023; 47: 1286-1301","DOI":"10.1038\/s41366-023-01388-0"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Lee CM, Huxley RR, Wildman RP, Woodward M. Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol, 2008; 61: 646-653","DOI":"10.1016\/j.jclinepi.2007.08.012"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Hsieh SD, Muto T. Metabolic syndrome in Japanese men and women with special reference to the anthropometric criteria for the assessment of obesity: Proposal to use the waist-to-height ratio. Prev Med, 2006; 42: 135-139","DOI":"10.1016\/j.ypmed.2005.08.007"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Ichikawa T, Okada H, Nakajima H, Yoneda M, Ushigome E, Hamaguchi M, Kurogi K, Murata H, Tsuda E, Yoshida N, Ito M, Fukui M. Anthropometric indices for predicting incident cardiovascular disease: a 13-year follow-up study in a Japanese population. Am J Clin Nutr, 2025; 122: 954-961","DOI":"10.1016\/j.ajcnut.2025.08.010"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Maeda T, Yoshimura C, Takahashi K, Ito K, Yasuno T, Abe Y, Masutani K, Nakashima H, Mukoubara S, Arima H. Usefulness of the blood pressure classification in the new 2017 ACC\/AHA hypertension guidelines for the prediction of new-onset chronic kidney disease. J Hum Hypertens, 2019; 33: 873-878","DOI":"10.1038\/s41371-019-0198-7"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Ishida S, Kondo S, Funakoshi S, Satoh A, Maeda T, Kawazoe M, Yoshimura C, Tada K, Takahashi K, Ito K, Yasuno T, Masutani K, Nakashima H, Arima H. White blood cell count and incidence of hypertension in the general Japanese population: ISSA-CKD study. PLoS One, 2021; 16: e0246304","DOI":"10.1371\/journal.pone.0246304"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Okutsu S, Kato Y, Funakoshi S, Maeda T, Yoshimura C, Kawazoe M, Satoh A, Yokota S, Tada K, Takahashi K, Ito K, Yasuno T, Fujii H, Mukoubara S, Nakashima H, Kawanami D, Masutani K, Arima H, Nabeshima S. Effects of Weight Gain after 20 Years of Age and Incidence of Hyper-Low-Density Lipoprotein Cholesterolemia: The Iki Epidemiological Study of Atherosclerosis and Chronic Kidney Disease (ISSA-CKD). J Clin Med, 2021; 10: 3098","DOI":"10.3390\/jcm10143098"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Kawano K, Ueno T, Maeda T, Nohara C, Maki K, Iwanaga K, Morinaga A, Funakoshi S, Abe M, Satoh A, Kawazoe M, Yoshimura C, Takahashi K, Tada K, Ito K, Yasuno T, Mukobara S, Kawanami D, Masutani K, Arima H. Relationship between abdominal circumference and the incidence of hyperuricemia in the general Japanese population. Sci Rep, 2024; 14: 4573","DOI":"10.1038\/s41598-024-55008-6"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Sakaguchi T, Funakoshi S, Kawano K, Ueno T, Maki K, Morinaga A, Iwanaga K, Inoue Y, Shinohara Y, Katsuki S, Takahashi K, Ishida S, Fujii T, Abe M, Kawazoe M, Maeda T, Yoshimura C, Tada K, Ito K, Mukobara S, Masutani K, Inoue T, Nagamitsu S, Arima H. Non-fasting and fasting serum triglyceride concentrations and new-onset hyperuricemia in the general Japanese population: ISSA-CKD study. Sci Rep, 2025; 15: 5764","DOI":"10.1038\/s41598-025-90196-9"},{"key":"33","unstructured":"33) Iki City, Nagasaki. https:\/\/www.city.iki.nagasaki.jp\/. Accessed 5 Nov. 2025"},{"key":"34","unstructured":"34) Iki City. Iki City Elderly Welfare Plan and 9th Nursing Care Insurance Business Plan 2025. https:\/\/www.city.iki.nagasaki.jp\/material\/files\/group\/38\/gaiyou.pdf. Accessed 8 Jul. 2025"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Tokushige A, Ueda S, Tomiyama H, Ohishi M, Kohro T, Higashi Y, Takase B, Suzuki T, Ishizu T, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Yamashina A. Association Between Waist-to-Height Ratio and Endothelial Dysfunction in Patients With Morbidity - A Report From the FMD-J Study. Circ J, 2017; 81: 1911-1918","DOI":"10.1253\/circj.CJ-17-0211"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Bays HE, Kirkpatrick CF, Maki KC, Toth PP, Morgan RT, Tondt J, Christensen SM, Dixon DL, Jacobson TA. Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024. J Clin Lipidol, 2024; 18: e320-e350","DOI":"10.1016\/j.jacl.2024.04.001"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Choi SH, Ginsberg HN. Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance. Trends Endocrinol Metab, 2011; 22: 353-363","DOI":"10.1016\/j.tem.2011.04.007"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol, 2011; 11: 85-97","DOI":"10.1038\/nri2921"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Roumans KHM, Lindeboom L, Veeraiah P, Remie CME, Phielix E, Havekes B, Bruls YMH, Brouwers MCGJ, St\u00e5hlman M, Alssema M, Peters HPF, de Mutsert R, Staels B, Taskinen MR, Bor\u00e9n J, Schrauwen P, Schrauwen-Hinderling VB. Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance. Nat Commun, 2020; 11: 1891","DOI":"10.1038\/s41467-020-15684-0"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/advpub\/0\/advpub_66242\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:52:44Z","timestamp":1788583964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/advpub\/0\/advpub_66242\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":39,"URL":"https:\/\/doi.org\/10.5551\/jat.66242","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"66242"}}